Grazia Alessio

Grazia Alessio

Auto-generated profile, based on publicly available information

Grazia Alessio

Infectious Diseases, Department of Systems Medicine, Tor Vergata University , Rome

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
AIAlessandra Imeneo
Alessandra Imeneo
DZDrieda Zace
Drieda Zace
Fabio massimo OddiFabio massimo Oddi
Fabio massimo Oddi
GAGrazia Alessio
Grazia Alessio
LFLudovica Ferrari
Ludovica Ferrari
LSLoredana Sarmati
Loredana Sarmati
Background: Prosthetic vascular graft infection (PVGI) is a rare but life-threatening complication. Graft replacement is the only curative option, but often unfeasible due to high mortality risk. Suppressive antimicrobial therapy (SAT) offers a viable alternative, though evidence on regimens and duration is limited. Methods: We conducted a retrospective study, reviewing records of PVGI patients during 2014–2025 aiming to evaluate the efficacy of SAT. SAT was considered effective when allowing infection control under treatment; patients were defined as cured if no relapse occurred after at least 6 months from discontinuation. Patients were classified according to the Management of Aortic Graft Infection Collaboration criteria and managed by a multidisciplinary team. Results: Thirty patients met the inclusion criteria; 5 underwent graft removal and 25 underwent SAT. Infections were diagnosed a median of 90 [30–1095] days postsurgery. Fever occur in 15/25 (60%) and abscess in 12/25 (48%) patients. Microbiological diagnosis was achieved in 17/25 (68%) cases. A long-acting antibiotic (LAA) was used in 6/25 (24%), with successful discontinuation in 3/6. Drug adverse events occurred in 8/25 (32%) patients and treatment failure was observed in 11 among all antibiotic regimens analyzed. Infection control during SAT was achieved in 10 (40%) patients. Ten patients discontinued SAT and 6/10 (60%) remained relapse-free after more than 6 months of follow-up. Conclusions: SAT is a valuable option for high-risk PVGI patients. LAA may represent an option. PET/CT remains key for diagnosis and monitoring. Further studies are needed to define optimal SAT duration and to improve long-term outcomes.